Get the latest Science News and Discoveries

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of Clinical Trial

Clinical Trial

Photo of Breakthrough

Breakthrough

Photo of % remission rate

% remission rate

Related news:

Researchers say a world-first cancer vaccine is delivering results even better than they had hoped for. The “transformational” breakthrough is detailed in a study that found a 42% reduction in the risk of melanoma recurrence.

A new, randomized and placebo-controlled clinical trial suggests that taking vitamin C daily could improve survival in people with precancerous blood disorders and early-stage blood cancers

Kansai Medical University Hospital administers world’s first dose of DS1025 in an international early phase 1 clinical trial

« Dental implants can hijack your immune system, scientists discover

MIT scientists build a tiny robot that swims using living muscle cells »